Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 3546 entries
View as:

To Evaluate the Incidence of Acute Otitis Media in Children in Five East European Countries

Phase: N/A Priority: Normal
NCT ID: NCT01365390 Org: User:
Start: 06/30/11 End: 12/31/12 Due: 12/31/13

Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00085878 Org: User:
Start: 01/31/03 End: - Due: -

Influenza Burden Assessment in the United Kingdom, 1996-2008

Phase: N/A Priority: Normal
NCT ID: NCT01520935 Org: User:
Start: 09/30/11 End: 05/31/12 Due: 05/31/13

Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04937387 Org: User:
Start: 07/29/21 End: 08/05/24 Due: 08/05/25

Study Of GW679769 In Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00102492 Org: User:
Start: 10/31/04 End: 09/30/06 Due: 09/30/07

A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients

Phase: N/A Priority: Normal
NCT ID: NCT00349427 Org: User:
Start: 10/31/05 End: - Due: -

A Phase 1, Open Label Study of Intravenous GSK3745417 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Determine RP2D & Schedule in Participants With Relapsed or Refractory Myeloid Malignancies Including AML and HR MDS

Phase: N/A Priority: Normal
NCT ID: NCT05424380 Org: User:
Start: 09/20/22 End: 03/04/24 Due: 03/04/25

Pharmacokinetic Study of Levocetirizine Oral Solution

Phase: N/A Priority: Normal
NCT ID: NCT01622283 Org: User:
Start: 05/02/12 End: 06/10/12 Due: 06/10/13

SB-681323-Methotrexate Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT00419809 Org: User:
Start: 05/31/05 End: 12/31/05 Due: 12/31/06

Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

Phase: N/A Priority: Normal
NCT ID: NCT00317187 Org: User:
Start: 06/08/04 End: 01/16/05 Due: 01/16/06

Study of SB681323 and Prednisolone on Biomarkers in COPD (Chronic Obstructive Pulmonary Disease) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00380133 Org: User:
Start: 06/30/05 End: 04/30/06 Due: 04/30/07

HuMax-CD20 in Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00093314 Org: User:
Start: 10/31/04 End: 01/31/07 Due: 01/31/08

GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)

Phase: N/A Priority: Normal
NCT ID: NCT02528357 Org: User:
Start: 09/11/15 End: 04/29/20 Due: 04/29/21

Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23)

Phase: N/A Priority: Normal
NCT ID: NCT00169507 Org: User:
Start: 03/31/05 End: 04/30/05 Due: 04/30/06

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Phase: N/A Priority: Normal
NCT ID: NCT02853929 Org: User:
Start: 09/19/16 End: 03/19/19 Due: 03/19/20

To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT02853435 Org: User:
Start: 08/04/16 End: 10/17/17 Due: 10/17/18

A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole

Phase: N/A Priority: Normal
NCT ID: NCT00422994 Org: User:
Start: 04/30/06 End: 12/31/06 Due: 12/31/07

Effect of Topical Application of Iodex® Balm on Local Surface Temperature

Phase: N/A Priority: Normal
NCT ID: NCT02424565 Org: User:
Start: 05/31/15 End: 06/30/15 Due: 06/30/16

Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States

Phase: N/A Priority: Normal
NCT ID: NCT03973905 Org: User:
Start: 02/15/19 End: 05/15/19 Due: 05/15/20

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02776033 Org: User:
Start: 08/30/16 End: 01/04/18 Due: 01/04/19

A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT03443427 Org: User:
Start: 03/20/18 End: 09/23/20 Due: 09/23/21

A Phase I Study of Pazopanib in Adult Patients With Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00370513 Org: User:
Start: 12/06/06 End: 04/08/09 Due: 04/08/10

Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Patient-derived Organoids and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT06405230 Org: User:
Start: 03/31/25 End: 06/30/28 Due: 06/30/29

Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber

Phase: N/A Priority: Normal
NCT ID: NCT00377728 Org: User:
Start: 03/31/06 End: 05/31/06 Due: 05/31/07

Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety

Phase: N/A Priority: Normal
NCT ID: NCT01567995 Org: User:
Start: 02/28/08 End: 02/10/09 Due: 02/10/10